Suhail Abdullah

Suhail Abdullah is the Chief Scientific Officer at New World Medical, a position he has held since January 2018. He is based in Rancho Cucamonga, California, and has extensive experience in clinical and regulatory affairs within the medical device industry, particularly in ophthalmology.

Professional Background

• Chief Scientific Officer (2018 - Present): In this role, Abdullah oversees pre-clinical studies, manages clinical evaluation reports (CERs), and ensures compliance with medical device regulations. He has played a crucial role in transitioning the company's products from the Medical Device Directive (MDD) to the Medical Device Regulation (MDR) standards.14
• Previous Roles: Before becoming the Chief Scientific Officer, he served as the Chief Scientific Officer for Clinical/Regulatory Affairs from March 2015 to December 2017 and held various positions including Director of Research and Development and Product Development Manager at New World Medical since 2003.12

Key Contributions

Abdullah has been instrumental in:

• Leading product development initiatives for medical devices, particularly glaucoma treatments.
• Establishing a clinical/medical affairs department that oversees multiple post-market clinical studies.
• Engaging with FDA reviewers to ensure successful study designs and regulatory submissions.13

Education and Expertise

Suhail Abdullah is recognized for his problem-solving skills and leadership in medical device strategy and product development. His expertise encompasses clinical evidence management, regulatory compliance, and post-market surveillance activities.14

Overall, Suhail Abdullah's contributions to New World Medical highlight his commitment to advancing ophthalmic medical devices while ensuring patient safety and regulatory adherence.